IL91500A0 - Protein of paramyxovirus,method for the production thereof and vaccine containing the same - Google Patents

Protein of paramyxovirus,method for the production thereof and vaccine containing the same

Info

Publication number
IL91500A0
IL91500A0 IL91500A IL9150089A IL91500A0 IL 91500 A0 IL91500 A0 IL 91500A0 IL 91500 A IL91500 A IL 91500A IL 9150089 A IL9150089 A IL 9150089A IL 91500 A0 IL91500 A0 IL 91500A0
Authority
IL
Israel
Prior art keywords
paramyxovirus
protein
production
same
vaccine containing
Prior art date
Application number
IL91500A
Original Assignee
Molecular Eng Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Eng Ass filed Critical Molecular Eng Ass
Publication of IL91500A0 publication Critical patent/IL91500A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL91500A 1988-09-02 1989-09-01 Protein of paramyxovirus,method for the production thereof and vaccine containing the same IL91500A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24087788A 1988-09-02 1988-09-02

Publications (1)

Publication Number Publication Date
IL91500A0 true IL91500A0 (en) 1990-04-29

Family

ID=22908302

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91500A IL91500A0 (en) 1988-09-02 1989-09-01 Protein of paramyxovirus,method for the production thereof and vaccine containing the same

Country Status (8)

Country Link
EP (1) EP0433371A4 (en)
JP (1) JPH04501058A (en)
AU (1) AU4314489A (en)
DK (1) DK37591D0 (en)
IL (1) IL91500A0 (en)
NZ (1) NZ230425A (en)
WO (1) WO1990002566A1 (en)
ZA (1) ZA896715B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE105334T1 (en) * 1988-04-22 1994-05-15 Upjohn Co CHIMAERIC GLYCOPROTEINS CONTAINING IMMUNOGENIC SECTIONS OF HUMAN PARAINFLUENZAVIRUS TYPE 3.
JP2649285B2 (en) * 1990-11-29 1997-09-03 藤倉化成株式会社 Human parainfluenza 4A virus fusion protein gene and substance containing the gene
NZ243611A (en) * 1991-07-17 1993-12-23 Commw Scient Ind Res Org Vaccine and its preparation for treating rhabdovirus and paramyxovirus
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US5298239A (en) * 1991-10-07 1994-03-29 The Research Foundation Of State University Of New York Mutations rendering platelet glycoprotein IB α less reactive
DE4407489A1 (en) * 1994-03-07 1995-09-14 Bayer Ag Vaccine for the prevention of respiratory and reproductive diseases of the pig
US5641751A (en) * 1995-05-01 1997-06-24 Centocor, Inc. Tumor necrosis factor inhibitors
MXPA06008496A (en) 2004-02-02 2007-01-30 Ambrx Inc Modified human interferon polypeptides and their uses.
MXPA06014684A (en) 2004-06-18 2007-02-12 Ambrx Inc Novel antigen-binding polypeptides and their uses.
WO2009100255A2 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
BRPI0518661A2 (en) 2004-12-22 2008-12-02 Ambrx Inc Methods for expression and purification of recombinant human growth hormone
US7638491B2 (en) 2004-12-22 2009-12-29 Ambrx, Inc. Therapies using non-natural amino acids and polypeptides
KR101224781B1 (en) 2004-12-22 2013-01-21 암브룩스, 인코포레이티드 Formulations of human growth hormone comprising a non-naturally encoded amino acid
MX2007007580A (en) 2004-12-22 2007-12-11 Ambrx Inc Modified human growth hormone.
ATE541934T1 (en) 2004-12-22 2012-02-15 Ambrx Inc AMINOACYL TRNA SYNTHETASE COMPOSITIONS AND USES THEREOF
EP1893229B1 (en) 2005-06-03 2011-10-19 Ambrx, Inc. Improved human interferon molecules and their uses
PT2339014E (en) 2005-11-16 2015-10-13 Ambrx Inc Methods and compositions comprising non-natural amino acids
CA2662753C (en) 2006-09-08 2016-02-23 Ambrx, Inc. Hybrid suppressor trna for vertebrate cells
CN106008699A (en) 2006-09-08 2016-10-12 Ambrx公司 Modified human plasma polypeptide or Fc scaffolds and their uses
US8420792B2 (en) 2006-09-08 2013-04-16 Ambrx, Inc. Suppressor tRNA transcription in vertebrate cells
EP2068909B1 (en) 2007-03-30 2012-04-25 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
JP5547083B2 (en) 2007-11-20 2014-07-09 アンブルックス，インコーポレイテッド Modified insulin polypeptides and their use
US10138283B2 (en) 2008-07-23 2018-11-27 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
CN107022020A (en) 2008-09-26 2017-08-08 Ambrx公司 The animal erythropoietin polypeptides and its purposes of modification
MX348657B (en) 2008-09-26 2017-06-21 Ambrx Inc Non-natural amino acid replication-dependent microorganisms and vaccines.
AU2010341516B2 (en) 2009-12-21 2014-01-16 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
CA2784800A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
SG10201506443TA (en) 2010-08-17 2015-10-29 Ambrx Inc Modified relaxin polypeptides and their uses
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
AR083006A1 (en) 2010-09-23 2013-01-23 Lilly Co Eli FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME
LT3412302T (en) 2014-10-24 2021-07-26 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
US10266578B2 (en) 2017-02-08 2019-04-23 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus
US4847081A (en) * 1984-07-18 1989-07-11 W. R. Grace & Co.-Conn. Synthetic bovine parainfluenza viral proteins
JPS6226300A (en) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Cloning and developping of htlv-iii dna

Also Published As

Publication number Publication date
AU4314489A (en) 1990-04-02
WO1990002566A1 (en) 1990-03-22
NZ230425A (en) 1992-07-28
EP0433371A4 (en) 1991-10-30
JPH04501058A (en) 1992-02-27
DK37591A (en) 1991-03-01
DK37591D0 (en) 1991-03-01
ZA896715B (en) 1990-09-26
EP0433371A1 (en) 1991-06-26

Similar Documents

Publication Publication Date Title
IL91500A0 (en) Protein of paramyxovirus,method for the production thereof and vaccine containing the same
GB8901469D0 (en) Proteins and method for their production
AR244036A1 (en) Transponder and method for the production thereof
EP0188388A3 (en) Alpha-alumina particles, and process for preparing the same
DE3661339D1 (en) Protein hydrolysates, production process and drugs containing th em
AU581835B2 (en) Adsorbent for separation - recovery of CO, preparing method thereof and process for separation - recovery of high purity CO, using the adsorbent
EP0228612A3 (en) A derivative of alpha, alpha-trehalose and a process for preparing the same
AU6686686A (en) Aerochocolates and process for preparing the same
AU3101689A (en) Process for the preparation of cyclic sulphates
EP0192485A3 (en) Titanium dioxide particles, and process for preparing the same
AU591719B2 (en) Benzylamine derivatives, process for production thereof, and use thereof
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
IL78874A0 (en) Method of preparing vaccines and process for the production thereof
GB2201540B (en) Magnetic head and method for the production thereof
AU4460989A (en) Fixation element and method for its production
AU2501288A (en) Sialocylglycerolipids and method for preparing the same
AU2267188A (en) One-way valve, method for the production thereof and the use of the valve
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
ZA894941B (en) Process for the production of proteins
HUT40621A (en) Process for production of derivatives of guanidin, e.g. linoglyride and the intermediers
EP0359118A3 (en) Method for the production of 1,1,2-trialkoxyethanes
EP0344112A3 (en) Substituted bisacyloxynaphthacenes, and process for the preparation of tetrathiotetracenes
DE3664473D1 (en) Epoxysteroid ucy1003 and process for preparing the same
AU579734B2 (en) New process for making polyesters, polyamides and poliketones
EP0290888A3 (en) 2-methyl-4-amino-5-aminomethyl-pyrimidine carbonate, process for preparing the same and method of purification of 2-methyl-4-amino-5-aminomethylpyrimidine using the same